News & Updates

Physical activity, SBP tied to thoracic aortic size

08 Oct 2024

Hard physical activity and normotensive individuals and increasing systolic blood pressure (SBP) in those with hypertension each correlate with larger thoracic aortic size, suggests a study.

Physical activity, SBP tied to thoracic aortic size

08 Oct 2024

Sacubitril/valsartan vs enalapril for paediatric HF a toss-up in head-to-head trial

07 Oct 2024 by

Sacubitril/valsartan appears to be safe and beneficial in the treatment of children with heart failure (HF) attributable to systemic left ventricular systolic dysfunction (LVSD), with the drug having comparable efficacy as enalapril, according to the 52-week data from the phase 2/3 PANORAMA-HF* trial.

Sacubitril/valsartan vs enalapril for paediatric HF a toss-up in head-to-head trial

07 Oct 2024

Pulmonary arterial hypertension outcomes better with early therapy augmentation with selexipag

04 Oct 2024 by

In the treatment of patients with pulmonary arterial hypertension, adding selexipag as a third medication sooner rather than later is crucial to help prevent hospitalization and disease progression, as suggested in an emulated target trial.

Pulmonary arterial hypertension outcomes better with early therapy augmentation with selexipag

04 Oct 2024

Ever considered interrupting the β-blocker in a stable post-MI patient? ABYSS suggests don’t

04 Oct 2024 by

In stable post-MI patients without a reduced EF who have been on long-term β-blockers, interrupting the β-blocker treatment instead of continuing it leads to more hospitalizations for CV reasons and does not improve QoL, as shown in the phase III ABYSS trial presented at ESC 2024

Ever considered interrupting the β-blocker in a stable post-MI patient? ABYSS suggests don’t

04 Oct 2024

The FINEART of finerenone: A new option for HFmrEF/HFpEF?

03 Oct 2024 by

Full results of the phase III FINEARTS-HF trial have shown that finerenone cuts the risk of worsening heart failure (HF) events and cardiovascular (CV) death in symptomatic HF with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF).

The FINEART of finerenone: A new option for HFmrEF/HFpEF?

03 Oct 2024

Novel AI tool for predicting cardio-cerebrovascular disease risk among Chinese

03 Oct 2024 by

Researchers at the University of Hong Kong (HKU) have developed an innovative artificial intelligence (AI) assessment model that has the potential to fundamentally change the prevention and management of cardio-cerebrovascular (CCV) diseases specifically in the Chinese population.

Novel AI tool for predicting cardio-cerebrovascular disease risk among Chinese

03 Oct 2024

Colchicine helps with plaque stabilization in acute coronary syndrome

02 Oct 2024

In patients with acute coronary syndrome, the use of colchicine appears be beneficial in terms of coronary plaque stabilization as assessed on optical coherence tomography, according to a study.

Colchicine helps with plaque stabilization in acute coronary syndrome

02 Oct 2024

Contralateral differences in ankle SBP, PWV up risk of heart failure, death in older adults

01 Oct 2024

A study has shown that contralateral differences in ankle systolic blood pressure (SBP) and pulse wave velocity (PWV) are predictive of increased mortality risk among older adults.

Contralateral differences in ankle SBP, PWV up risk of heart failure, death in older adults

01 Oct 2024

Leisure-time physical activity prevents arterial stiffness in adults

01 Oct 2024

Adults who engage in leisure-time physical activity (LTPA) may benefit from better cardiometabolic health and are less likely to experience large artery stiffening, suggests a study.

Leisure-time physical activity prevents arterial stiffness in adults

01 Oct 2024

TAVI superior to surgery in women with aortic stenosis

01 Oct 2024 by

In women with severe symptomatic aortic stenosis (AS), transcatheter aortic valve implantation (TAVI) is superior to conventional surgery in terms of reducing death, stroke, and rehospitalization at 1 year, according to the RHEIA* trial presented at ESC 2024.

TAVI superior to surgery in women with aortic stenosis

01 Oct 2024

News & Updates

Filter by Specialty:

Specialty:

Physical activity, SBP tied to thoracic aortic size

Physical activity, SBP tied to thoracic aortic size

Sacubitril/valsartan vs enalapril for paediatric HF a toss-up in head-to-head trial

Sacubitril/valsartan vs enalapril for paediatric HF a toss-up in head-to-head trial

Pulmonary arterial hypertension outcomes better with early therapy augmentation with selexipag

Pulmonary arterial hypertension outcomes better with early therapy augmentation with selexipag

Ever considered interrupting the β-blocker in a stable post-MI patient? ABYSS suggests don’t

Ever considered interrupting the β-blocker in a stable post-MI patient? ABYSS suggests don’t

The FINEART of finerenone: A new option for HFmrEF/HFpEF?

The FINEART of finerenone: A new option for HFmrEF/HFpEF?

Novel AI tool for predicting cardio-cerebrovascular disease risk among Chinese

Novel AI tool for predicting cardio-cerebrovascular disease risk among Chinese

Colchicine helps with plaque stabilization in acute coronary syndrome

Colchicine helps with plaque stabilization in acute coronary syndrome

Contralateral differences in ankle SBP, PWV up risk of heart failure, death in older adults

Contralateral differences in ankle SBP, PWV up risk of heart failure, death in older adults

Leisure-time physical activity prevents arterial stiffness in adults

Leisure-time physical activity prevents arterial stiffness in adults

TAVI superior to surgery in women with aortic stenosis

TAVI superior to surgery in women with aortic stenosis